These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 7648383)
1. The beta 2-agonist controversy revisited. McFadden ER Ann Allergy Asthma Immunol; 1995 Aug; 75(2):173-6. PubMed ID: 7648383 [TBL] [Abstract][Full Text] [Related]
2. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma. Fahy JV; Boushey HA Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410 [TBL] [Abstract][Full Text] [Related]
3. Long-and short-acting beta 2-adrenergic agonists. Effects on airway function in patients with asthma. Busse WW Arch Intern Med; 1996 Jul; 156(14):1514-20. PubMed ID: 8687259 [TBL] [Abstract][Full Text] [Related]
4. Safety of long-acting beta2-agonists in the treatment of asthma. Cazzola M; Matera MG Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346 [TBL] [Abstract][Full Text] [Related]
5. What is new with the beta2-agonists: issues in the management of asthma. Kelly HW Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904 [TBL] [Abstract][Full Text] [Related]
6. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response. Peters S Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066 [TBL] [Abstract][Full Text] [Related]
7. Risk versus benefit considerations for the beta(2)-agonists. Kelly HW Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063 [TBL] [Abstract][Full Text] [Related]
8. [Beta-agonists: new perspective in the treatment of asthma?]. Quadrelli SA; Roncoroni AJ; Pinna DM Medicina (B Aires); 1999; 59(3):293-9. PubMed ID: 10451572 [TBL] [Abstract][Full Text] [Related]
9. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma. Hui KP Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893 [TBL] [Abstract][Full Text] [Related]
10. Is there a problem with inhaled long-acting beta-adrenergic agonists? Nelson HS J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577 [TBL] [Abstract][Full Text] [Related]
11. New developments in bronchodilator therapy. Nelson HS Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113 [TBL] [Abstract][Full Text] [Related]
12. Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis. Hancox RJ Clin Rev Allergy Immunol; 2006; 31(2-3):279-88. PubMed ID: 17085800 [TBL] [Abstract][Full Text] [Related]
14. Are mast cells all bad? Page CP Postgrad Med J; 1991; 67 Suppl 4():S6-11; discussion S12. PubMed ID: 1684662 [TBL] [Abstract][Full Text] [Related]
15. The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Sears MR; Taylor DR Drug Saf; 1994 Oct; 11(4):259-83. PubMed ID: 7848546 [TBL] [Abstract][Full Text] [Related]
16. [The controversy: use of beta-stimulants and mortality in asthma: analysis of a recent article]. Allerg Immunol (Paris); 1992 Mar; 24(3):99-100. PubMed ID: 1350912 [No Abstract] [Full Text] [Related]
17. Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? Beasley R; Pearce N; Crane J; Burgess C J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S18-30. PubMed ID: 10452785 [TBL] [Abstract][Full Text] [Related]
18. The proper role of beta 2-adrenergic agonists in the treatment of children with asthma. Furukawa CT; Kemp JP; Simons FE; Tinkelman DG Pediatrics; 1992 Oct; 90(4):639-40. PubMed ID: 1357623 [No Abstract] [Full Text] [Related]
19. The beta-agonist controversy. Taylor DR; Sears MR; Cockcroft DW Med Clin North Am; 1996 Jul; 80(4):719-48. PubMed ID: 8676612 [TBL] [Abstract][Full Text] [Related]
20. [Is fenoterol therapy related to increased asthma mortality?]. Boe J; Kongerud J; Bodd E Tidsskr Nor Laegeforen; 1992 Feb; 112(5):661-3. PubMed ID: 1557737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]